With approval, additional Johnson & Johnson vaccine could inoculate U.S. by summer

Johnson & Johnson's COVID-19 vaccine is showing an efficacy of 86%, down from previous vaccines that set a high bar, but with another option on the horizon there is hope of vaccinating everyone in the U.S. by this summer.

Latest Videos

Mornings on 2

View More
View More